seasonal flu vaccines

Leadership & Management Samsung mobile chief fills leadership void in device division

Samsung Electronics Co. has appointed TM Roh, president and head of its mobile eXperience (MX) business, as the new chief of its device eXperience (...

Korean chipmakers SK Hynix’s HBM exports plummet, now susceptible to seasonal demand

Exports of SK Hynix Inc.'s multi-chip packages (MCP), including high-bandwidth memory (HBM) AI chips, are rapidly dropping as the South Korean chipm...

Bio & Pharma SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

Automobiles Kia reveals teaser images of The New Sportage

South Korea's Kia Corp. unveiled the teaser images and videos of The New Sportage, the facelift model of Kia's flagship compact sport utility vehicl...

Bio & Pharma SK Bioscience's SKYCellflu approved in Indonesia

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

Investment banking Junior bankers choosing track records over name value

A number of junior bankers at the Korean offices of major global investment banks such as Morgan Stanely and J.P.Morgan have resigned since July wit...

Korean startups Enormous market ahead for Hopae, S.Korean DID pioneer

To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...

Bio & Pharma SK Bioscience sells stake in US vaccine developer Novavax

SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...

Mergers & Acquisitions SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn

South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...

Bio & Pharma EuBiologics gets WHO certification for cholera vaccine facility

South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...

Entertainment Hasty overseas expansion hurts Korean entertainment sector

South Korea’s entertainment and content industries suffered from hasty expansions with investments of billions of dollars in the global market...

Bio & Pharma SK Bioscience exports Sky Cellflu to Thailand

South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...

Artificial intelligence LG to use AI for early detection of air conditioner anomalies

LG Electronics Inc. has introduced an artificial intelligence technology for early detection of anomalies in its commercial air conditioning systems...

Automobiles Hankook Tire unveils all-season tire Kinergy XP in N.America

South Korea's Hankook Tire & Technology announced on Wednesday that it will launch its all-season grand touring tire Kinergy XP in the North Ame...

Bio & Pharma SK Bioscience start to deliver Novavax COVID-19 vaccine

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

Entertainment Toho buys 25% stake in CJ ENM’s Fifth Season for $225 mn

Toho Co. has acquired a 25% stake in Fifth Season for $225 million, a move expected to be a win for not only the money-losing US-based producer-dist...

Bio & Pharma SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

Bio & Pharma Korea to invest $200 mn in new drugs, vaccines by 2028

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...

Bio & Pharma GC Biopharma wins $10 mn order for flu vaccine in Thailand

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...

Bio & Pharma KAIST, IVI to collaborate on global vaccine research

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...

Bio & Pharma SK Bioscience to develop 2nd-generation Ebola vaccine

South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...

Earnings Korean tire makers post double-digit Q3 profit margins; outlook bright

South Korea’s three leading tire makers posted their highest-ever quarterly profit margins in the third quarter, boosted by tire price hikes, ...

Bio & Pharma S.Korean vaccine developer Quratis eyes Iraqi market

South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...

Travel & Leisure Overseas trips top pre-pandemic levels during Chuseok holiday

The number of South Koreans who spent this year’s six-day holiday of Chuseok abroad exceeded pre-pandemic levels, indicating a recovery in the...

Bio & Pharma EuBiologics, GC Biopharma to jointly produce cholera vaccine

South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...

Bio & Pharma POSCO Int'l marks 1st animal vaccine exports

POSCO International Corp., the general trading and energy exploration unit of South Korea's steel giant POSCO Holdings Inc., announced on Thursday t...

Bio & Pharma SK Bioscience resumes output of flu vaccine after two years

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...

Bio & Pharma SK Bioscience to export $51 bn flu vaccine to Thailand

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...

Airlines Korean Air’s operating profit falls to $360 mn in Q2 2023

Korean Air Lines Co.’s operating profit in the second quarter fell over 30% from the same period last year in line with market consensus.Consi...

Bio & Pharma LG Chem to make first domestic 6-in-1 vaccine for infants

South Korea's LG Chem Ltd. will produce the nation's first homegrown six-in-one vaccine for infants, something that the country is entirely reliant ...